PHARMATROPHIX INC — Form D/A

PHARMATROPHIX INC of RALEIGH, NC, a company, filed a Form D amendment with the SEC on 2015-11-20. The offering totals $10.3M, of which $10.3M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2015-11-20
Form: D/A
Accession: 0001425819-15-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $10.3M
Amount sold: $10.3M
Investors: 15
Date of first sale: 2014-06-27
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-220714

Issuer

Name: PHARMATROPHIX INC
CIK: 0001425819
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2005
Address: C/O SMITH ANDERSON ET AL, RALEIGH, NC, 27601
Phone: 919-821-6733

Officers, directors & promoters (7)

Name	Role	Location
Frank M Longo	Director	Menlo Park, CA
Robert M Sims	Director	Menlo Park, CA
Anne C Longo	Executive Officer	Menlo Park, CA
Sallie M Shuping-Russell	Director	Sunnyvale, CA
Frank M. Longo	Director	Menlo Park, CA
Anne C. Longo	Executive Officer	Menlo Park, CA
Sallie M. Shuping-Russell	Director	Durham, NC

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2014-07-10	D	$9.5M	$5.3M
2013-10-25	D	$250K	$250K
2012-09-10	D	$2.0M	$800K
2010-03-15	D	$180K	$180K

More